These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 17200165

  • 1. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, Courtney R, Rejto P, Carley W, Stewart PM.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [Abstract] [Full Text] [Related]

  • 2. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP, Corrigan M, Gathercole L, Taylor A, Hughes B, Gaoatswe G, Manolopoulos K, Hogan AE, O'Connell J, Stewart PM, Tomlinson JW, O'Shea D, Sherlock M.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [Abstract] [Full Text] [Related]

  • 3. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
    Prasad Sakamuri SS, Sukapaka M, Prathipati VK, Nemani H, Putcha UK, Pothana S, Koppala SR, Ponday LR, Acharya V, Veetill GN, Ayyalasomayajula V.
    PLoS One; 2012 Apr; 7(12):e50216. PubMed ID: 23284633
    [Abstract] [Full Text] [Related]

  • 4. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
    Anderson S, Carreiro S, Quenzer T, Gale D, Xiang C, Gukasyan H, Lafontaine J, Cheng H, Krauss A, Prasanna G.
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
    [Abstract] [Full Text] [Related]

  • 5. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ, Stimson RH, Tan GD, Homer NZ, Andrew R, Karpe F, Walker BR.
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [Abstract] [Full Text] [Related]

  • 6. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR.
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [Abstract] [Full Text] [Related]

  • 7. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM.
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [Abstract] [Full Text] [Related]

  • 8. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S, Quinkler M, Mai K, Schöneshöfer M, Baehr V, Pfeiffer A, Oelkers W, Eigendorff E.
    Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
    [Abstract] [Full Text] [Related]

  • 9. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y, Yan C, Liu L, Wang W, Du H, Fan W, Lutfy K, Jiang M, Friedman TC, Liu Y.
    Am J Physiol Endocrinol Metab; 2015 Jan 01; 308(1):E84-95. PubMed ID: 25389364
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
    Akiyama N, Akiyama Y, Kato H, Kuroda T, Ono T, Imagawa K, Asakura K, Shinosaki T, Murayama T, Hanasaki K.
    J Pharmacol Exp Ther; 2014 Apr 01; 349(1):66-74. PubMed ID: 24511146
    [Abstract] [Full Text] [Related]

  • 12. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue.
    Gathercole LL, Morgan SA, Bujalska IJ, Hauton D, Stewart PM, Tomlinson JW.
    PLoS One; 2011 Apr 01; 6(10):e26223. PubMed ID: 22022575
    [Abstract] [Full Text] [Related]

  • 13. Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition.
    Gómez C, Alimajstorovic Z, Othonos N, Winter DV, White S, Lavery GG, Tomlinson JW, Sinclair AJ, Odermatt A.
    Br J Pharmacol; 2024 Mar 01; 181(5):698-711. PubMed ID: 37740611
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
    Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI, Stewart PM.
    QJM; 2003 Jul 01; 96(7):481-90. PubMed ID: 12881590
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM, Toogood AA, Tomlinson JW.
    Horm Res; 2001 Jul 01; 56 Suppl 1():1-6. PubMed ID: 11786677
    [Abstract] [Full Text] [Related]

  • 16. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
    Tiganescu A, Hupe M, Uchida Y, Mauro T, Elias PM, Holleran WM.
    Endocrinology; 2018 Jan 01; 159(1):547-556. PubMed ID: 29087473
    [Abstract] [Full Text] [Related]

  • 17. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S, Richardt A, Remer T, Wudy SA, Tomlinson JW, Hughes B, Grüters A, Stewart PM, Strasburger CJ, Quinkler M.
    Eur J Endocrinol; 2007 Sep 01; 157(3):319-24. PubMed ID: 17766714
    [Abstract] [Full Text] [Related]

  • 18. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM.
    J Bone Miner Res; 2002 Jun 01; 17(6):979-86. PubMed ID: 12054173
    [Abstract] [Full Text] [Related]

  • 19. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH, Andersson J, Andrew R, Redhead DN, Karpe F, Hayes PC, Olsson T, Walker BR.
    Diabetes; 2009 Jan 01; 58(1):46-53. PubMed ID: 18852329
    [Abstract] [Full Text] [Related]

  • 20. Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy.
    Dineen RA, Martin-Grace J, Ahmed KMS, Taylor AE, Shaheen F, Schiffer L, Gilligan LC, Lavery GG, Frizelle I, Gunness A, Garrahy A, Hannon AM, Methlie P, Eystein SH, Stewart PM, Tomlinson JW, Hawley JM, Keevil BG, O'Reilly MW, Smith D, McDermott J, Healy ML, Agha A, Pazderska A, Gibney J, Behan LA, Thompson CJ, Arlt W, Sherlock M.
    J Clin Endocrinol Metab; 2023 Nov 17; 108(12):3178-3189. PubMed ID: 37339332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.